<DOC>
	<DOCNO>NCT02467855</DOCNO>
	<brief_summary>The purpose study evaluate blood pressure ( BP ) goal attainment adult participant essential hypertension .</brief_summary>
	<brief_title>Epidemiological Study Thai Participants With Hypertension</brief_title>
	<detailed_description>This study design non-interventional , observational study obtain information hypertension treatment regimens well hypertension control Thai patient real-life setting . Antihypertensive medication prescribe study discretion investigator standard care practice particular study site . The study enroll approximately 2000 patient . Participants well-controlled hypertension current antihypertensive therapy participate study 1 visit . Participants history hypertension uncontrolled current antihypertensive medication participant newly diagnose hypertension ( diagnose within past 4 week uncontrolled antihypertensive therapy ) observe course 12-16 week . These participant make 3 visit study site . This multi-centre trial conduct Thailand .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<criteria>1 . Ability provide write informed consent 2 . Age 18 year . 3 . Participants essential hypertension per European Society Hypertension/European Society Cardiology ( ESH/ESC ) criteria general , target blood pressure ( BP ) , systolic blood pressure ( SBP ) &lt; 140 diastolic blood pressure ( DBP ) &lt; 90 mmHg , diabetes , target BP , SBP &lt; 140 DBP &lt; 85 mmHg , renal disease overt proteinuria ( urine albumin excretion &gt; 300 mg/day 200 microgram/min ) , target BP , SBP &lt; 130 DBP &lt; 90 mmHg ) . Essential Hypertension define base criterion establish ESH/ESC 2013 criterion : Grade 1 Essential hypertension Systolic blood pressure ( SBP ) 140 159 mmHg and/or diastolic blood pressure ( DBP ) 9099 mmHg identifiable cause Grade 2 Essential hypertension SBP 160 179 mmHg and/or DBP 100 109 mmHg identifiable cause Grade 3 Essential hypertensionSBP ≥ 180 and/or DBP ≥ 110 mmHg identifiable cause . 1 . Female participant breastfeed pregnant intend become pregnant . 2 . Has know suspect secondary hypertension . 3 . Is currently enrol yet complete least 30 day since end investigational product device study receive investigational agent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Drug therapy</keyword>
</DOC>